These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23011539)

  • 1. Polymorphisms in Factor II and Factor V thrombophilia genes among Circassians in Jordan.
    Dajani R; Arafat A; Hakooz N; Al-Abbadi Z; Yousef AM; El Khateeb M; Quadan F
    J Thromb Thrombolysis; 2013 Jan; 35(1):83-9. PubMed ID: 23011539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR G677A among 594 thrombotic Jordanian patients.
    Eid SS; Shubeilat T
    Blood Coagul Fibrinolysis; 2005 Sep; 16(6):417-21. PubMed ID: 16093732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of coagulation factor II G20210A and factor V G1691A Leiden polymorphisms in Chechans, a genetically isolated population in Jordan.
    Dajani R; Fatahallah R; Dajani A; Al-Shboul M; Khader Y
    Mol Biol Rep; 2012 Sep; 39(9):9133-8. PubMed ID: 22744422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran.
    Rahimi Z; Vaisi-Raygani A; Mozafari H; Kharrazi H; Rezaei M; Nagel RL
    J Thromb Thrombolysis; 2008 Jun; 25(3):280-3. PubMed ID: 17700999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians.
    Eid SS; Rihani G
    Clin Lab Sci; 2004; 17(4):200-2. PubMed ID: 15559724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
    Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M
    Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the prothrombin G20210A mutation with factor V Leiden in a midwestern American population.
    Bavikatty NR; Killeen AA; Akel N; Normolle D; Schmaier AH
    Am J Clin Pathol; 2000 Aug; 114(2):272-5. PubMed ID: 10941343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of heterozygosity for the factor V Leiden and factor II G20210A mutations on the risk of thrombosis in Greek patients.
    Hatzaki A; Anagnostopoulou E; Metaxa-Mariatou V; Melissinos C; Philalithis P; Iliadis K; Kontaxis A; Liberatos K; Pangratis N; Nasioulas G
    Int Angiol; 2003 Mar; 22(1):79-82. PubMed ID: 12771861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.
    Rahimi Z; Vaisi-Raygani A; Nagel RL; Muniz A
    J Thromb Thrombolysis; 2008 Jun; 25(3):288-92. PubMed ID: 17619828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.
    Rahimi Z; Nomani H; Mozafari H; Vaisi-Raygani A; Madani H; Malek-Khosravi S; Parsian A
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):252-6. PubMed ID: 19349859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid multiplex analysis for the factor V Leiden and prothrombin G20210A mutations associated with hereditary thrombophilia.
    Linfert DR; Rezuke WN; Tsongalis GJ
    Conn Med; 1998 Sep; 62(9):519-25. PubMed ID: 9785636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
    Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The frequency of factor V Leiden and prothrombin G20210A mutations in Slovak and Roma (Gypsy) ethnic group of Eastern Slovakia.
    Bôžiková A; Gabriková D; Sovičová A; Behulová R; Mačeková S; Boroňová I; Petrejčíková E; Soták M; Bernasovská J; Bernasovský I
    J Thromb Thrombolysis; 2012 Oct; 34(3):406-9. PubMed ID: 22562116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
    Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
    J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical evaluation of primer engineered multiplex polymerase chain reaction-restriction fragment length polymorphism for detection of factor V Leiden and prothrombin G20210A.
    Huber S; McMaster KJ; Voelkerding KV
    J Mol Diagn; 2000 Aug; 2(3):153-7. PubMed ID: 11229520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factor V Leiden and prothrombin G20210A among Chilean patients with venous and arterial thrombosis].
    Palomo I; Pereira J; Alarcón M; Pinochet C; Vélez MT; Hidalgo P; Skagerberg K; Poblete F
    Rev Med Chil; 2005 Dec; 133(12):1425-33. PubMed ID: 16446869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
    Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
    Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Contributions of Thrombophilic Mutations to Genetic Susceptibility to Deep Venous Thrombosis in Iraqi Patients.
    Al-Allawi NA; Badi AI; Goran MA; Nerweyi FF; Ballo HM; Al-Mzury NT
    Genet Test Mol Biomarkers; 2015 Sep; 19(9):500-4. PubMed ID: 26196588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.